AL Amyloidosis - 146 Studies Found Completed : Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 2007-05-23 : Biological: filgrastim No admi Terminated : Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation : Drug/Agent Toxicity by Tissue/Organ Multiple Myeloma and Plasma Cell Neoplasm : 2003-01-24 : Biological: filgrastim Drug: amifostine tr Active, not recruiting : A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) : Light Chain (AL) Amyloidosis Cardiac Involvement : 2013-11-18 : Drug: Epigallocatechin-3-gallate (EGCG) Active, not recruiting : Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis : Multiple Myeloma : 2004-01-09 : Drug: filgrastim 16 mg/kg/day Terminated : 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis : Multiple Myeloma Plasma Cell Neoplasm : 2004-01-09 : Biological: filgrastim 16mcg/k Completed : Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 2001-01-06 : Biological: filgrastim Biological: recombi Withdrawn : Mixed Chimeric Transplantation for Primary Amyloidosis : : 2024-11-25 Active, not recruiting : Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis : Amyloidosis : 2009-11-02 : Drug: Bortezomib Completed : Autologous Stem Cell Rescue for Primary Amyloidosis : Amyloidosis Blood and Marrow Transplant (BMT) : 2005-09-13 : Procedure: high dose chemo then auto hematopoietic cell transplant Completed : Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis : Amyloidosis : 2005-09-12 : Drug: CC-5013 40 mg/day orally on days 1-4 and 15-18 of each 28-day cycle <<< Previous | Next >>>
